Biomarin Pharmaceutical Inc
BMRN
$57.5+0.33 (+0.58%)
Jul 5, 2025, 4:00 PM
Financials
| 52Week High | 94.85 | 52Week Low | 52.93 |
| Beta | 0.34 | Current Ratio Annual | 5.33 |
| Current Ratio Quarterly | 5.52 | Gross Margin TTM | 79.44 |
| Market Cap | 11.03B | Net Profit Margin TTM | 17.76 |
| Operating Margin TTM | 21.00 | Price To Book | 1.90 |
| Price To Earnings TTM | 21.05 | Price To Free Cash Flow TTM | 17.78 |
| Price To Sales TTM | 3.74 | Quick Ratio Annual | 3.29 |
| Quick Ratio Quarterly | 3.49 | Return On Assets TTM | 7.47 |
| Return On Equity TTM | 9.46 | Return On Investment TTM | 8.37 |
| Revenue Growth3Y | 15.62 | Revenue Growth5Y | 10.86 |
| Revenue Growth Quarterly Yoy | 14.84 | Revenue Growth TTMYoy | 19.36 |
| Revenue Per Share TTM | 15.02 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 570 | 89 | 60 | 232 | 176 | 61 | 184.22M | $12.66B |
| Jun 30, 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $0 |
| Change | 570(100%) | 89(100%) | 60(100%) | 232(100%) | 176(100%) | 61(100%) | 184.22M(100%) | $12.66B(100%) |